Two rat studies tie Selank to lower stress-induced brain inflammation

The first study used a model of chronic social stress in rats, a way to mimic long-term social conflict in a lab ¹. In stressed rats, the hippocampus, a brain region for memory and emotion, showed a clear immune imbalance ¹. Three cytokines that call immune cells into tissue, often called pro-inflammatory signals, rose to between two and 3.8 times the levels seen in unstressed rats ¹. Two calming cytokines fell by 32 to 37 percent ¹.

Rats that received Selank before the stress sessions had a smaller jump in those pro-inflammatory signals ¹. Compared with stressed rats that got no peptide, pro-inflammatory cytokines dropped by 33 to 45 percent ¹. The calming cytokines rose by 30 to 42 percent ¹. A longer tuftsin derivative in the same study had an even larger effect, cutting pro-inflammatory signals by roughly half ¹. The data show Selank moderated the stress response, but they do not show whether giving it after stress would do the same ¹.

The second study used a transient blockage of the middle cerebral artery in rats, a standard way to model an ischemic stroke ². Four and a half hours after the blockage, researchers used RNA sequencing to read which genes were active in the frontal cortex ². In the group that received saline, the injury switched on many genes tied to immune activity ². When rats received Selank, 99 of the 118 genes that changed after Selank were calmed down ². Sixty of those had been switched on by the stroke alone ².

Those 99 genes mapped to two broad processes: nerve signaling and immune activity, including antigen presentation and the complement system ². Antigen presentation is how cells show pieces of foreign material to immune cells, and the complement system is a set of proteins that helps clear damaged cells ². The study found Selank reduced the gene-level disruptions caused by ischemia, rather than adding a separate large effect ².

Both studies looked at immune signals inside the brain. In the social stress model, that shift showed up as a rise in pro-inflammatory cytokines and a drop in calming ones ¹. In the stroke model, it showed up as altered activity in genes for antigen presentation and complement ². Selank's effect in both cases was to reduce the size of those shifts ¹.

That does not necessarily mean Selank makes a brain recover faster. The studies measured signals, not outcomes, so they cannot separate a helpful immune response from a harmful one ¹.

These 2026 findings sit alongside older work on Selank and immune signaling. A 2011 mouse study found that Selank changed the expression of inflammation-related genes in the spleen, a tissue that filters blood and helps coordinate immunity ³. A later transcriptomic study also reported that single and repeated Selank injections changed gene activity in the rat hippocampus and spleen ⁴.

Three studies share a common endpoint, a shift in immune-related gene or cytokine signals.

Study	Model	Main immune finding
2011 spleen study 3	Mice, gene expression in spleen	Changed inflammation-related gene expression
2026 social stress study 1	Rats, social stress, hippocampus	Lowered stress-driven pro-inflammatory cytokines and restored calming ones
2026 ischemia study 2	Rats, early stroke, frontal cortex	Reduced ischemia-induced immune gene changes

The table shows a consistent direction across different models, but the measurements are not the same, so the studies cannot be combined into one exact number ¹.

The newer rat data add an immune layer to a compound that has mostly been studied for anxiety and cognition. Earlier research tied Selank to the brain's calming system, GABA, and to higher levels of BDNF, a protein that supports nerve health ⁵. Human imaging work has also shown that Selank given through the nose changes connectivity in brain areas involved in emotion ⁸. The 2026 studies do not replace that picture; they suggest the immune system may be part of why Selank shows effects under stress or injury ¹.

Still, the two new studies used different readouts. One measured protein-level cytokines in the hippocampus after social stress ¹. The other measured gene expression in the frontal cortex after stroke ². Both found a shift toward normal, but neither measured behavior, memory, or tissue survival ¹. That keeps the findings at the molecular level for now ¹.

These two studies were short-term and done in rats. They do not tell us whether the same shifts happen in people, or whether repeated use over weeks would hold the immune signal steady ¹. The social stress study gave Selank before the stress, so it leaves open whether the peptide would help after stress has already built up ¹. The stroke study looked at gene activity 4.5 hours after injury, so it cannot speak to later outcomes ².

The social stress study also found that another tuftsin derivative had a stronger cytokine effect than Selank ¹. That does not make Selank less interesting, but it shows the peptide is not the strongest performer in every immune comparison ¹. Future research would need to test whether these molecular shifts lead to fewer signs of tissue damage or better brain function ².

In the research so far, Selank's most consistent new signal is a moderating effect on brain immune reads, not a proven repair effect ¹.